China Medical News

since 2011, because of the obviously declining batch release of biological products YOY influenced by the implementation of new version GMP, the export amount of biochemical drugs keeps a slow growth rate.

Monoclonal antibody still belongs to high-end products in Chinese market, mainly depending on imports.

Co-founder Derek Muhs transitions from role as CEO to Group President and Dr Steve Liu, PhD appointed as new Group CEO.

WA Regenerative Medicine signed a milestone agreement today with University of Southern California, which aims at sharing research, and applying breakthrough medicine to help improve the lives of people in the Greater China Region.

WA Stem Cell Technologies signs partnership agreement with YiRen Cancer Hospital.

The first 5-star service world-class health center has officially opened its doors to the Chinese market. The Grand Opening of the WA Optimum Health Care Center took place in Shanghai in the historical XingGuo Gardens on February 28, 2011.

Contec CMS-M Multi-function Stethoscope integrate with regular stethoscope, ECG waveform display, heart and pulse oximeter, so it has a strong fuction. It also can change SpO2 sensor for different patient (neonate, infant, child, and adult).

since 2011, because of the obviously declining batch release of biological products YOY influenced by the implementation of new version GMP, the export amount of biochemical drugs keeps a slow growth rate.

Monoclonal antibody still belongs to high-end products in Chinese market, mainly depending on imports.

Co-founder Derek Muhs transitions from role as CEO to Group President and Dr Steve Liu, PhD appointed as new Group CEO.

Jinzanghuang Tibet Pharmaceuticals, Inc. (JZHG.OB), today announced the financial results for the six months ended December 31, 2011. Net income increased 1019% or $0.08 per basic and diluted earnings per share.

Through attending the annual meeting, CMCI has given excellent impressions on cow-breeding companies, and is expected to seek for further development opportunities.

Many people are traveling to China’s top tier cities, not for business or vacation, but to receive medical treatments unavailable in their home countries, such as stem cell therapies.

November 11, 2011 AdvaCare Expanding into East European Market

Medical Care Technologies Inc. (OTCBB: MDCE), a children's health care service provider, today announced it has closed its third round of convertible note financing that to date has raised $752,500 for the Company.

Summary: The visit to terminal clients from Jinzanghuang, which has improved the company’s reputation, is expected to expand the marketing effects, and to make further relationships with the clients.

WA Regenerative Medicine signed a milestone agreement today with University of Southern California, which aims at sharing research, and applying breakthrough medicine to help improve the lives of people in the Greater China Region.

WA signs contract to implement clinical trials of mesenchymal stem cell treatment of Parkinson’s disease.

Crystal Pharmatech Co., Ltd successfully concluded a two-day workshop on polymorphism and crystallization of pharmaceuticals at Zhangjiang Biotech and Pharmaceutical Base (Zhangjiang Drug Valley) in Shanghai, China on September 15th and 16th.

Medical Care Technologies Inc. (OTCBB: MDCE), a rapidly growing children's healthcare service provider, has named Dr. Mark J. Langweiler as Medical Director of its Integrated Health Program.

WA Stem Cell Technologies signed an agreement to secure space in Shanghai Ju-Ke Biotech Park, designed to support biotechnologies, pharmaceutical research and development and clinical research.

Announcing Professor Dai Jianping as President of the WA Stem Cell Technologies Medical and Technology Board

WA Stem Cell Technologies signs partnership agreement with YiRen Cancer Hospital.

Dr Annie Zhao, MD joins WA Optimum Health Care Center in Shanghai, treating family members of all ages. Dr Annie Zhao MD, FRACGP Family Medicine

WA has launched their "Personal Doctor Card" in China, providing access to a team of international world-class physicians to manage individual and family health.

China MBBS creates opportunity for students to study MBBS in China in various Chinese Medical Universities. We are a complete trustful source for students making their future in Doctorate studies and provide the window to learn more about China.

China’s human vaccine market has expanded in recent years, growing at a CAGR of 24.0% in 2007-2010. In particular, the market scale in 2010 hit RMB10.3 billion, up 14.4% year-on-year.

Korean cosmetic surgeons present the latest technology at WA Optimum Health Care Center in Shanghai.

We have fully exerted the educational resources in Chinese Universities and established nice cooperation with Domestic and Overseas Universities, Educational Institution and Educational Counseling Center.

Cosmetic surgeon Dr Mark Berman, 2010 President of the American Academy of Cosmetic Surgery will be returning to Shanghai next week to lecture in the WA Optimum Health Care Center in Shanghai.

Dr Sheena Burnell appointed as Director of Cosmetic Department at WA Optimum Health Care, Shanghai

At the beginning of the 12th Five-Year Plan Period (2011-2015), some large pharmaceutical enterprises began to enter the biopharmaceutical field, laying a foundation and providing the impetus.

WA Optimum Health Care organizes series of public service events to educate on radiation.

In 2010, China's ophthalmic preparation market realized about CNY 6.90 billion, increasing by about 8.20% YOY.

Survey shows that in China, the proportion of children aged 0-4 who suffer from respiratory diseases and digestive system diseases in the age group suffering from them accounts for about 80% and 10% respectively, totaling up to 90%.

Cosmetic surgeon Dr Mark Berman, 2010 President of the American Academy of Cosmetic Surgery will be returning to Shanghai next week to lecture in the WA Optimum Health Care Center in Shanghai.

New appointment of Andy Chan as Chief Financial Officer to WA Optimum Health Care in China

The first 5-star service world-class health center has officially opened its doors to the Chinese market. The Grand Opening of the WA Optimum Health Care Center took place in Shanghai in the historical XingGuo Gardens on February 28, 2011.

ResearchInChina, the vertical portal for Chinese business intelligence, announces the release of a new report - China Oral Hypoglyceimic Agents (OHAs) Industry Report, 2010

ResearchInChina, the vertical portal for Chinese business intelligence, announces the release of a new report - China Interventional Cardiovascular Device Industry Report, 2010.

ResearchInChina, the vertical portal for Chinese business intelligence, announces the release of a new report - China Insulin Industry Report, 2010.

After completing the clinical trial on over 30 patients with effectiveness at 100%, Sino Stem Cells, introduces diabetes clinically. 62.9% reduced insulin dosage by 50%. 3.7% of Type 1 and 11.1% of Type 2 could completely stop insulin injections.

WA Optimum Health Care, offering the best primary, integrative and aesthetic health care under 1 roof in a 5 star setting has opened in a beautiful garden in central Shanghai, China.

Wujing General Hospital announced the launch of the Arabic version of its website, as one of the steps towards improving the quality of its international patient services.

The common animal vaccines at present are mainly applied in such mammals as pigs, cattle, sheep and bird species. In fact, fish and other aquatic products are also in demand for vaccines.

China's market demand for blood products has not been well met. It is estimated that the number of Chinese hemophiliacs reaches 80,000-100,000, 4 / 5 of which are lack of factor Ⅷ.

The Ministry of Health of China introduced new regulations governing the clinical use of stem cells. We provide a quick digest of the laws regulating new biotechnologies including stem cell treatments in China which came into force from 1 May 2009.

New study from Wujing General Hospital provides insights into the working mechanisms of neural stem cell in the regeneration of central nervous system, that may help to develop novel therapies to restore lost functions.

Secretary of the Wuxi Municipal Committee of the CPC Attends Launch of WA Bio-tech Facilities in Wuxi, China.

Angiotech Pharmaceuticals, Inc. a specialty pharmaceutical and medical device company, announced the closing of its acquisition of certain product candidates and technology assets of Haemacure Corporation.

"Bronchitis-Drug Pipeline Analysis and Market Forecasts to 2016" is an essential source of information and analysis on the global bronchitis market. The report identifies the key trends shaping and driving the global bronchitis market.

Report provides essential source of information and analysis on the global allergic conjunctivitis market. The report identifies the key trends shaping and driving the global allergic conjunctivitis market. The

GlobalData's pharmaceutical and healthcare report, "Hemophilia-Drug Pipeline Analysis and Market Forecasts to 2016".

In 2009, the total sales in Chinese chemical pharmaceutical industry reached CNY 424.24 billion, rising by 18.24% YOY.

GlobalData has released a pharmaceutical and healthcare report, "Hepatitis C-Drug Pipeline Analysis and Market Forecasts to 2016".

GlobalData's pharmaceutical and healthcare report offering, "Pneumonia-Drug Pipeline Analysis and Market Forecasts to 2016". is an essential source of information and analysis on the global pneumonia market.